Search results
Results from the WOW.Com Content Network
The power of phakic lens is independent of the axial length of the eye. Rather it depends on central corneal power, anterior chamber depth (ACD) and patient refraction (preoperative spherical equivalent). The most common formula for calculating the power of phakic IOL is the following: [2]
A phakic IOL. An intraocular lens (IOL) is a lens implanted in the eye usually as part of a treatment for cataracts or for correcting other vision problems such as near-sightedness (myopia) and far-sightedness (hyperopia); a form of refractive surgery.
Phakic IOL: Phakic intraocular lens are lenses that implanted inside eye without removing the normal crystalline lens. Phakic IOLs can be used to correct hypermetropia up to +20 diopters. [22] Non laser procedures
Phakic intraocular lens implantation inside the eye can also be used to change refractive errors. The newest type of intervention is a type of PIOL called the implantable collamer lens ( ICL ) which uses a biocompatible flexible lens which can be inserted in the eye via a 3 mm incision.
The aim of an accurate intraocular lens power calculation is to provide an intraocular lens (IOL) that fits the specific needs and desires of the individual patient. The development of better instrumentation for measuring the eye's axial length (AL) and the use of more precise mathematical formulas to perform the appropriate calculations have significantly improved the accuracy with which the ...
Iris-fixated intraocular lens is an intraocular lens that is implanted surgically into the eye and attached to the iris. Originally developed for aphakia, phakic versions have also been produced to correct myopia (nearsightedness), hyperopia (farsightedness), and astigmatism.
Angle-supported intraocular lenses are a special kind of intraocular lens that can be implanted surgically into the anterior chamber of the eye. These lenses are called angle-supported because the footplates of the lens rest in the irido-corneal angle.
The AMO portfolio already included the Amadeus II microkeratome, the Verisyse phakic IOL, and the ReZoom, Array and Tecnis IOLs. In Jan. 16, 2007 AMO announced the acquisition of privately held WaveFront Sciences Inc., a provider of wavefront diagnostic systems for refractive surgery and medical research, for $20 million in cash.